A surface-enhanced Raman scattering-based probe method for detecting chromogranin A in adrenal tumors

Nanomedicine (Lond). 2020 Feb;15(4):397-407. doi: 10.2217/nnm-2019-0436. Epub 2020 Jan 27.

Abstract

Aim: We aim to demonstrate that a surface-enhanced Raman spectroscopy (SERS) probe can be effectively used for protein detection in adrenal tumors. Materials & methods: The SERS probe method, which uses Au@Ag core-shell nanoparticles conjugated with a CgA antibody and a SERS reporter, was applied to detect CgA in adrenal tumors. Results: Our data reveal that the results of the CgA-SERS probe method were almost identical to those of western blot and superior to those of traditional immunohistochemistry. Conclusion: This study offers a novel strategy to detect CgA in adrenal tumors and provides more reliable protein test results than traditional immunohistochemistry analysis for adrenal pathologists, meaning that it might be a better clinical reference for the diagnosis of pheochromocytoma.

Keywords: Raman imaging; chromogranin A; immunohistochemistry; pheochromocytoma; surface-enhanced Raman scattering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms / metabolism*
  • Blotting, Western
  • Chromogranin A / metabolism*
  • Humans
  • Immunohistochemistry
  • Pheochromocytoma / metabolism
  • Spectrum Analysis, Raman / methods*

Substances

  • Chromogranin A